A- A A+

USA. Judge Grants Class Action Status to Methadone-Taper Jail Lawsuit

A federal judge has paved the way for a case against a methadone-taper policy at Cook County Jail, Illinois to proceed as a class action lawsuit. (Filter, USA, 07.12.2020)


Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study. 

Liebrenz, M., Gamma, A., Buadze, A. et al.

Harm Reduct J 17, 67 (2020). doi.org/10.1186/s12954-020-00412-0


Bayern. Auf Entzug: Fehlende Behandlung für Heroinabhängige in Haft?

Heroinsucht gilt als schwere chronische Krankheit. Doch in bayerischen Gefängnissen werden Heroinersatzbehandlungen immer wieder abgebrochen. Experten kritisieren das scharf. (BR24, 28.10.2020)


Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study. 

von Bernuth K, Seidel P, Krebs J, Lehmann M, Neumann B, Konrad N, Opitz-Welke A. 

Front Psychiatry. 2020 Aug 12;11:794. doi: 10.3389/fpsyt.2020.00794. PMID: 32903474; PMCID: PMC7435061.


Rapid upscale of depot buprenorphine (CAM2038) in custodial settings during the early COVID‐19 pandemic in New South Wales, Australia.

Roberts, J., White, B., Attalla, D., Ward, S., and Dunlop, A. (2020) 

Addiction. doi.org/10.1111/add.15244


OUD Care Service Improvement with Prolonged-release Buprenorphine in Prisons: Cost Estimation Analysis. 

Wright N, Hard J, Fearns C, Gilman M, Littlewood R, Clegg R, Parimelalagan L, Alam F. 

Clinicoecon Outcomes Res. 2020;12:499-504, doi.org/10.2147/CEOR.S256714


The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic Review. 

Seval N, Wurcel A, Gunderson CG, Grimshaw A, Springer SA. 

Infect Dis Clin North Am. 2020;34(3):559-584. doi:10.1016/j.idc.2020.06.011


Hepatitis C in the criminal justice system: opportunities for global action in the era of viral hepatitis elimination. 

Akiyama MJ. 

BMC Med. 2020;18(1):208. Published 2020 Aug 14. doi:10.1186/s12916-020-01680-0


Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study 

Macmadu A, Adams JW, Bessey SE, et al. 

[published online ahead of print, 2020 Jul 8]. Int J Drug Policy. 2020;102841. doi:10.1016/j.drugpo.2020.102841


Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study 

Prisons: ignore them at our peril. 

Kamarulzaman A, Verster A, Altice FL. 

Curr Opin HIV AIDS. 2019;14(5):415-422. doi:10.1097/COH.0000000000000572

Prisons: ignore them at our peril. 

Reducing overdose after release from incarceration (ROAR): study protocol for an intervention to reduce risk of fatal and non-fatal opioid overdose among women after release from prison. 

Waddell EN, Baker R, Hartung DM, et al. 

Health Justice. 2020;8(1):18. Published 2020 Jul 10. doi:10.1186/s40352-020-00113-7

Reducing overdose after release from incarceration (ROAR): study protocol for an intervention to reduce risk of fatal and non-fatal opioid overdose among women after release from prison. 

Gesundheitsversorgung in Gefängnissen: Krank im Knast 

In deutschen Gefängnissen fehlt es an Geld, Personal und Medikamenten – mit teils dramatischen Folgen für die Häftlinge. (Die Tageszeitung, 04.08.2020)

Gesundheitsversorgung in Gefängnissen: Krank im Knast 

Risk factors for self-harm in prison: a systematic review and meta-analysis

Favril, Louis et al.

The Lancet Psychiatry, Volume 7, Issue 8, 682 - 691 


The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons-Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids. 

Buadze A, Baggio S, Schleifer R, et al. 

Front Psychiatry. 2020;11:395. Published 2020 May 14. doi:10.3389/fpsyt.2020.00395


Prisoners should not be left behind in HCV research and policies. 

Moazen, B., Stöver, H., Dolan, K. et al. 

Harm Reduct J 17, 33 (2020). doi.org/10.1186/s12954-020-00379-y


Report. Global Prison Trends 2020

This year, PRI’s flagship publication Global Prison Trends, published alongside the Thailand Institute of Justice, has been released at a crucial time as prisons worldwide are being pushed to breaking point by the COVID-19 pandemic. Global Prison Trends 2020 documents the chronic issues that have led to this human rights and public health crisis and the challenges facing criminal justice systems in responding to the global pandemic. (PENAL REFORM INTERNATIONAL, UK, April 2020)


Implementation of opioid maintenance treatment in prisons in North Rhine-Westphalia, Germany - a top down approach.

Böhmer K, Schecke H, Render I, Scherbaum N.

Subst Abuse Treat Prev Policy. 2020 Mar 10;15(1):21. doi: 10.1186/s13011-020-00262-w.


Asistencial and therapeutic continuity after release from prison: an urgent problem that requires solutions. The model applied in Catalonian prisons.

Turu E, Barnés I, Marco A.

Rev Esp Sanid Penit. 2019;21(3):153-160.

PMID: 32083278


A study of the reasons for prescribing and misuse of gabapentinoids in prison including their co-prescription with opioids and antidepressants.

Soni A, Walters P.

Int J Prison Health. 2019 Aug 27;16(1):67-77. doi: 10.1108/IJPH-01-2019-0004.



Buprenorphin-Depot: Annäherung an das Äquivalenzprinzip in Haft - Besondere Eignung von Buvidal® zur Substitutionstherapie in der JVA 

Mannheim/Lund, 13.12.2019 – Die 4. Gefängnismedizintage am 5. und 6. Dezember 2019 in Frankfurt stießen auf reges Interesse bei Medizinern und Pflegekräften im Vollzug. Dem von der Camurus GmbH unterstützten Symposium „Das Depot – neue Wege in der Behandlung der Opioidabhängigkeit im Justizvollzug“ wohnten etwa 200 Besucher*innen bei. Mit der wachsenden Verfügbarkeit des Buprenorphin-Depots in Justizvollzugsanstalten kann eine deutliche Annäherung an das geforderte Äquivalenzprinzip erreicht werden, so ein Fazit der Referate und nachfolgenden Diskussion. (Camurus, Mannheim/Lund, 13.12.2019)


Gender and drug policy: Exploring global innovative approaches to drug policy and incarceration

Across the Americas, drug policies have failed to make a significant dent in the drug trade, while corruption and organized crime continue to thrive. At the same time, these harmful drug policies disproportionately fall on the most vulnerable, including poor women who often enter the drug trade because of desperation, lack of opportunity, and coercion. Stuck in a vicious cycle, the incarceration of these women only heightens their situation of vulnerability and takes a toll on their families and communities. (IDCP, UK, 2017-2020, Artikelserie)


Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.

Malta M, Varatharajan T, Russell C, Pang M, Bonato S, Fischer B (2019) 

PLoS Med 16(12): e1003002. https://doi.org/10.1371/journal.pmed.1003002


Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine.

Blue TR, Gordon MS, Schwartz RP, Couvillion K, Vocci FJ, Fitzgerald TT, O'Grady KE.

Addict Sci Clin Pract. 2019 Dec 2;14(1):45. doi: 10.1186/s13722-019-0172-2.


Opioid substitution therapy for people living in German prisons—inequality compared with civic sector.

Stöver, H., Jamin, D., Michels, I.I. et al. 

Harm Reduct J 16, 72 (2019) doi:10.1186/s12954-019-0340-4


Freiburg/Brsg. "Wir schaffen das zusammen" 

Drei Insassen der Freiburger Justizvollzugsanstalt erzählen ihre Geschichten – über Methadon, Vatergefühle und Familienbesuche im Gefängnis. (Badische Zeitung, 20.12.2019)


Acceptability and efficacy of naltrexone for criminal justice‐involved individuals with opioid use disorder: a systematic review and meta‐analysis.

Bahji, A., Carlone, D., and Altomare, J. ( 2019) 

Addiction, doi.org/10.1111/add.14946.



USA. ‘First Shot is Free’: Hundreds Incarcerated in Michigan Offered Opioid Blocker Shots

The Michigan Department of Corrections says more than 20% of its inmates have an opioid-use disorder. Wayne County Jail, the state’s largest, has similar numbers. (AT Forum, USA, 19.12.2019)


UK. Report: Unlocking the evidence: Understanding suicide in prisons

People in prison are significantly more likely to die by suicide than people in the general population.

In 2018 alone, there were 92 self-inflicted deaths in prisons in England and Wales. At Samaritans, we see the enormous scale of emotional distress in prisons – last year alone we provided emotional support to people in prison more than 300,000 times. We also see the wide range of concerns that underpin their distress.

Our report, Unlocking the evidence: Understanding suicide in prisons, brings together data from the Samaritans service with analysis of the wider literature on suicide in prisons. The report deepens out understanding of the reasons behind the high rate of suicide in prisons. (Samaritans, UK, 2019)


Opioid Use Disorder Treatment Decision Making And Care Navigation Upon Release From Prison: A Feasibility Study.

Banta-Green CJ, Floyd AS, Vick K, Arthur J, Hoeft TJ, Tsui JI.

Subst Abuse Rehabil. 2019 Oct 22;10:57-67. doi: 10.2147/SAR.S192045. 


Europa. Status report on prison health in the WHO European Region. Copenhagen: WHO Regional Office for Europe; 2019. Licence: CC BY-NC-SA 3.0 IGO. 

Der Bericht enthält eine Analyse der erhobenen Daten zum Gesundheitsstatus von Häftlingen und den Gesundheitssystemen im Strafvollzug in 39 Ländern in der Europäischen Region der WHO.